Alignment Healthcare, Inc. $ALHC Shares Acquired by T. Rowe Price Investment Management Inc.

Key Points

• T. Rowe Price Investment Management increased its stake in Alignment Healthcare by 5.0%, acquiring an additional 429,071 shares, now holding nearly 9.08 million shares valued at approximately $169 million.
• Major institutional investors, including Wells Fargo and Barclays, have also adjusted their positions in Alignment Healthcare, with overall institutional ownership now at 86.19%.
• Analysts have mixed ratings on Alignment Healthcare, with an average price target of $18.56 and updates that include UBS raising its price target to $17.00 and Wall Street Zen downgrading to a "hold" rating.

T. Rowe Price Investment Management Inc. raised its position in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) by 5.0% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,078,113 shares of the company's stock after purchasing an additional 429,071 shares during the quarter. T. Rowe Price Investment Management Inc. owned 4.59% of Alignment Healthcare worth $169,035,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Hsbc Holdings PLC raised its holdings in shares of Alignment Healthcare by 254.5% in the 1st quarter. Hsbc Holdings PLC now owns 55,806 shares of the company's stock worth $1,027,000 after purchasing an additional 40,063 shares during the period. Wellington Management Group LLP raised its holdings in shares of Alignment Healthcare by 0.9% in the 1st quarter. Wellington Management Group LLP now owns 7,509,057 shares of the company's stock worth $139,819,000 after purchasing an additional 70,557 shares during the period. Northern Trust Corp raised its holdings in shares of Alignment Healthcare by 4.9% in the 1st quarter. Northern Trust Corp now owns 953,516 shares of the company's stock worth $17,754,000 after purchasing an additional 44,552 shares during the period. Algert Global LLC raised its holdings in shares of Alignment Healthcare by 37.1% in the 1st quarter. Algert Global LLC now owns 238,492 shares of the company's stock worth $4,441,000 after purchasing an additional 64,480 shares during the period. Finally, Raymond James Financial Inc. raised its holdings in shares of Alignment Healthcare by 31.1% during the 1st quarter. Raymond James Financial Inc. now owns 206,174 shares of the company's stock valued at $3,839,000 after buying an additional 48,901 shares during the period. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, President Dawn Christine Maroney sold 30,000 shares of the firm's stock in a transaction on Monday, July 14th. The stock was sold at an average price of $13.44, for a total transaction of $403,200.00. Following the transaction, the president directly owned 2,042,899 shares in the company, valued at $27,456,562.56. This trade represents a 1.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Hyong Kim sold 24,800 shares of the firm's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $16.00, for a total value of $396,800.00. Following the transaction, the insider owned 447,367 shares in the company, valued at $7,157,872. This trade represents a 5.25% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 624,153 shares of company stock valued at $9,037,301 over the last three months. 6.60% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities research analysts recently commented on ALHC shares. KeyCorp upgraded Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 target price on the stock in a report on Monday. Zacks Research upgraded Alignment Healthcare to a "hold" rating in a report on Friday, August 8th. Wall Street Zen downgraded Alignment Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, August 10th. UBS Group raised their target price on Alignment Healthcare from $16.00 to $17.00 and gave the company a "neutral" rating in a report on Friday, May 2nd. Finally, Barclays upgraded Alignment Healthcare from an "underweight" rating to an "equal weight" rating and raised their price objective for the company from $9.00 to $13.00 in a research note on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, Alignment Healthcare has an average rating of "Moderate Buy" and a consensus target price of $18.83.

Alignment Healthcare Stock Down 0.7%

NASDAQ ALHC traded down $0.1150 during mid-day trading on Monday, reaching $15.7250. 1,923,771 shares of the company's stock traded hands, compared to its average volume of 3,017,867. Alignment Healthcare, Inc. has a 1-year low of $8.65 and a 1-year high of $21.06. The company has a fifty day simple moving average of $13.77 and a 200-day simple moving average of $15.30. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29. The company has a market cap of $3.11 billion, a price-to-earnings ratio of -56.08 and a beta of 1.16.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, beating analysts' consensus estimates of ($0.07) by $0.14. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.Alignment Healthcare's quarterly revenue was up 49.0% on a year-over-year basis. During the same quarter last year, the firm earned ($0.13) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, equities research analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.